Treatment satisfaction is associated with improved quality of life in patients treated with inhaled treprostinil for pulmonary arterial hypertension

Table 5 Responsiveness of TSQM to patient-assessed global impression of change

	Patient impression of change (Baseline to week 12)*
	Same or less satisfied* (n = 1)	More satisfied (n = 18)	Much more satisfied (n = 42)	p ^†
Change in TSQM, mean ± SD
Effectiveness	−28 ± 0	+13 ± 18	+23 ± 21	0.02
Side effects	−75 ± 0	−2 ± 20	+3 ± 20	0.001
Convenience	+6 ± 0	+22 ± 18	+45 ± 26	0.002
Global satisfaction	−21 ± 0	+14 ± 22	+23 ± 24	0.10

Positive change in score indicates improvement.
5 missing.
* Includes any responses for “about the same”, “less satisfied”, or “much less satisfied”.
† ANOVA.

ISSN: 1477-7525